The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this “Connectivity Map” resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, post-perturbation transcriptomics data are particularly suited for training computational models because the causal relationship between known perturbations (cause) and the measured post-perturbation gene expression (effect) allows for the modelling of mechanistic processes [11].”
From Benchmarking foundation cell models for post-perturbation RNA-seq prediction (2025) · cites this paper as [11]
In the citing paper
“Both Alakwaa’ and Luo’s pipelines use the CLUE platform, a cloud-based platform developed by the LINCS Center for signature-gene based drug ranking61.”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [61]
In the citing paper
“For example, in a classic paradigm inflammatory bowel disease (IBD) signatures were derived from surgical specimens and intersected with Connectivity Map70 data representing transcriptional readouts across a number of cell lines in response to treatment with many hundreds of drugs using a novel pattern-matching algorithm71. From this research the anticonvulsant drug topiramate was identified and”
From Exploiting machine learning for end-to-end drug discovery and development (2019) · cites this paper as [71]
In the citing paper
“Useful tools will include maps of evolutionary conservation (108) and chromatin state (140), as well as databases of cell-state signatures, such as genome-wide expression patterns, that may integrate aspects of cell biology under resting and provoked conditions (141).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [141]
In the citing paper
“It has been shown that compounds eliciting similar transcriptional signatures tend to share mechanisms of action.170,207−209”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [207]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Self-citationMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Research works printed but not linked: 7
- K. B. Glaser et al., Mol. Cancer Ther.2, 151 (2003).
- A. E. Wakeling, M. Dukes, J. Bowler, Cancer Res.51, 3867 (1991).
- J. Y. Vanderhoek, M. B. Feinstein, Mol. Pharmacol.16, 171 (1979).
- H. Hieronymus et al. Cancer Cell in press.
- Q. Yao et al., Clin. Cancer Res.9, 4483 (2003).
- T. Kubota et al., Cancer Res.58, 3344 (1998).
- G. Wei et al. Cancer Cell in press.
Cited by
Items 1,001–1,037 of 1,037
Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing
Chan, J., Wang, X., Turner, J. A., Baldwin, N. E., & Gu, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz006 · Cited by 50
Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence
Duran-Frigola, M., Cigler, M., & Winter, G. E. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11098 · Cited by 50
Algorithmic fairness of machine learning models for Alzheimer disease progression
Yuan, C., Linn, K. A., & Hubbard, R. A. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.42203 · Cited by 49
In silico assessment of adverse drug reactions and associated mechanisms
Ivanov, S. M., Lagunin, A. A., & Poroikov, V. V. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.018 · Cited by 49
Zeng, B., Glicksberg, B. S., Newbury, P., Chekalin, E., Xing, J., Liu, K., Wen, A., Chow, C., & Chen, B. (2021) · Nature Protocols · doi:10.1038/s41596-020-00430-z · Cited by 48
Benchmarking foundation cell models for post-perturbation RNA-seq prediction
Csendes, G., Sanz, G., Szalay, K. Z., & Szalai, B. (2025) · BMC Genomics · doi:10.1186/s12864-025-11600-2 · Cited by 47
“Notably, post-perturbation transcriptomics data are particularly suited for training computational models because the causal relationship between known perturbations (cause) and the measured post-perturbation gene expression (effect) allows for the modelling of mechanistic processes [11].”
EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer
Katsyv, I., Wang, M., Song, W. M., Zhou, X., Zhao, Y., Park, S., Zhu, J., Zhang, B., & Irie, H. Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11870 · Cited by 47
Comprehensive pharmacogenomic characterization of gastric cancer
Sa, J. K., Hong, J. Y., Lee, I.-K., Kim, J.-S., Sim, M.-H., Kim, H. J., An, J. Y., Sohn, T. S., Lee, J. H., Bae, J. M., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-0717-8 · Cited by 46
Youthful and age-related matreotypes predict drugs promoting longevity
Statzer, C., Jongsma, E., Liu, S. X., Dakhovnik, A., Wandrey, F., Mozharovskyi, P., Zülli, F., & Ewald, C. Y. (2021) · Aging Cell · doi:10.1111/acel.13441 · Cited by 45
Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action
Ficek, J., Zygmunt, M., Piechota, M., Hoinkis, D., Rodriguez Parkitna, J., Przewlocki, R., & Korostynski, M. (2016) · BMC Genomics · doi:10.1186/s12864-016-2713-3 · Cited by 42
EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy
Zhou, X., Wang, M., Katsyv, I., Irie, H., & Zhang, B. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty325 · Cited by 43
Targeting SALL4 by entinostat in lung cancer
Yong, K. J., Li, A., Ou, W.-B., Hong, C. K. Y., Zhao, W., Wang, F., Tatetsu, H., Yan, B., Qi, L., Fletcher, J. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12251 · Cited by 41
“To search for potential existing drug(s) to treat SALL4expressing cancers, we conducted Connectivity Map (cMap) analysis [26, 27].”
MethodGHK and DNA: Resetting the human genome to health
Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2014) · BioMed Research International · doi:10.1155/2014/151479 · Cited by 39
The opportunities of mining historical and collective data in drug discovery
Wassermann, A. M., Lounkine, E., Davies, J. W., Glick, M., & Camargo, L. M. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.004 · Cited by 34
A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease
Lee, S. Y., Song, M.-Y., Kim, D., Park, C., Park, D. K., Kim, D. G., Yoo, J. S., & Kim, Y. H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01653 · Cited by 32
“Then we constructed a DGPSD comprised of 61,019 Drug-induced Gene Perturbation Signatures (DGPSs) generated by 1,520 compounds in 26 cell lines collected from CMap and L1000.”
MethodInfluentialRepresenting high throughput expression profiles via perturbation barcodes reveals compound targets
Filzen, T. M., Kutchukian, P. S., Hermes, J. D., Li, J., & Tudor, M. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005335 · Cited by 31
Sokolowski, M., Wasserman, J., & Wasserman, D. (2018) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32694 · Cited by 30
“We also performed a nonselective exploration of genes sets representing the in vitro effects on mRNA expression by psychotropic drugs in the connectivity map (Lamb et al., 2006), obtained by using online tool ToppGene (Chen et al.”
MethodBlattmann, P., Henriques, D., Zimmermann, M., Frommelt, F., Sauer, U., Saez-Rodriguez, J., & Aebersold, R. (2017) · Cell Systems · doi:10.1016/j.cels.2017.11.002 · Cited by 26
Formatting biological big data for modern machine learning in drug discovery
Duran‐Frigola, M., Fernández‐Torras, A., Bertoni, M., & Aloy, P. (2019) · WIREs Computational Molecular Science · doi:10.1002/wcms.1408 · Cited by 25
Tampe, B., Tampe, D., Nyamsuren, G., Klöpper, F., Rapp, G., Kauffels, A., Lorf, T., Zeisberg, E. M., Müller, G. A., Kalluri, R., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci89632 · Cited by 24
Issa, N. T., Kruger, J., Wathieu, H., Raja, R., Byers, S. W., & Dakshanamurthy, S. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1065-y · Cited by 22
Navigating Transcriptomic Connectivity Mapping Workflows to Link Chemicals with Bioactivities
Shah, I., Bundy, J., Chambers, B., Everett, L. J., Haggard, D., Harrill, J., Judson, R. S., Nyffeler, J., & Patlewicz, G. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00245 · Cited by 19
Role of NR4A family members in myeloid cells and leukemia
Boulet, S., Le Corre, L., Odagiu, L., & Labrecque, N. (2022) · Current Research in Immunology · doi:10.1016/j.crimmu.2022.02.001 · Cited by 17
Wang, X., Liu, M., Zhang, Y., He, S., Qin, C., Li, Y., & Lu, T. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab289 · Cited by 16
Network-Free Inference of Knockout Effects in Yeast
Peleg, T., Yosef, N., Ruppin, E., & Sharan, R. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000635 · Cited by 14
“As data from perturbation experiments in human gradually accumulates [22], this is an appealing direction for future research.”
BackgroundZhang, F., Zhong, W., Li, H., Huang, K., Yu, M., & Liu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.665265 · Cited by 13
“Mode-of-action (MoA) analysis was performed to figure out the potential mechanism of those candidate drugs (Lamb et al., 2006).”
BackgroundKriukov, D., Khrameeva, E. E., Gladyshev, V. N., Dmitriev, S. E., & Tyshkovskiy, A. (2022) · doi:10.1101/2022.12.12.520058 · Cited by 13
Parallel reverse genetic screening in mutant human cells using transcriptomics
Gapp, B. V., Konopka, T., Penz, T., Dalal, V., Bürckstümmer, T., Bock, C., & Nijman, S. M. (2016) · Molecular Systems Biology · doi:10.15252/msb.20166890 · Cited by 12
Pickart, L., Vasquez-Soltero, J. M., Pickart, F. D., & Majnarich, J. (2014) · Journal of Analytical Oncology · doi:10.6000/1927-7229.2014.03.02.2 · Cited by 12
Multidimensional profiling in the investigation of small-molecule-induced cell death
Wolpaw, A. J., & Stockwell, B. R. (2014) · Methods in Enzymology · doi:10.1016/b978-0-12-801430-1.00011-1 · Cited by 10
Meiners, S., & Eickelberg, O. (2012) · Genome Medicine · doi:10.1186/gm371 · Cited by 10
Prediction and identification of synergistic compound combinations against pancreatic cancer cells
KalantarMotamedi, Y., Choi, R. J., Koh, S.-B., Bramhall, J. L., Fan, T.-P., & Bender, A. (2021) · iScience · doi:10.1016/j.isci.2021.103080 · Cited by 8
Compound Activity Prediction with Dose-Dependent Transcriptomic Profiles and Deep Learning
Godinez, W. J., Trifonov, V., Fang, B., Kuzu, G., Pei, L., Guiguemde, W. A., Martin, E. J., King, F. J., Jenkins, J. L., & Skewes-Cox, P. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01855 · Cited by 7
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Self-citationZheng, Y., Schupp, J., Adams, T., Clair, G., Justet, A., Ahangari, F., Yan, X., Hansen, P., Carlon, M., Cortesi, E., et al. (2023) · doi:10.21203/rs.3.rs-3676579/v1 · Cited by 34
Wei, R., Dai, H., Zhang, J., Shih, D. J. H., Liang, Y., Xiao, P., McGrail, D. J., & Lin, S.-Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095008 · Cited by 4
“To this end, we used the Library of Integrated Network-based Cellular Signatures (LINCS), a catalogue of transcriptional alterations induced by treatment with various drugs or other perturbations [18].”
MethodSelf-citationZatorski, N., Sun, Y., Elmas, A., Dallago, C., Karl, T., Stein, D., Rost, B., Huang, K.-L., Walsh, M., & Schlessinger, A. (2024) · iScience · doi:10.1016/j.isci.2024.110640 · Cited by 2
Metadata
- Authors
- Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Crawford, Emily D.
- Golub, Todd R.
- ORCID
- Venue
- Science
- Published
- 2006-09-29
- Volume
- 313
- Issue
- 5795
- Pages
- 1929-1935
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2121604817
- Cited by
- 5,257
- References
- 41
- Citations by year
- 2026: 226 · 2025: 285 · 2024: 332 · 2023: 370 · 2022: 416 · 2021: 406 · 2020: 383 · 2019: 385 · 2018: 280 · 2017: 288 · 2016: 296 · 2015: 259 · 2014: 217 · 2013: 241 · 2012: 219
- FWCI
- 118.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene expression signatures, small molecules, drug action, gene perturbation, mechanism of action, cultured human cells, functional genomics
- MeSH terms
- Alzheimer Disease, Cell Line, Dexamethasone, Drug Evaluation, Preclinical, Enzyme Inhibitors, Estrogens, Humans, Obesity, Phenothiazines, Software, Gene Expression, Databases, Factual, HSP90 Heat-Shock Proteins, Drug Resistance, Neoplasm, Sirolimus, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Limonins, Cell Line, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.